» Articles » PMID: 23236477

Cytomegalovirus and Herpes Simplex Virus Effect on the Prognosis of Mechanically Ventilated Patients Suspected to Have Ventilator-associated Pneumonia

Overview
Journal PLoS One
Date 2012 Dec 14
PMID 23236477
Citations 53
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Cytomegalovirus (CMV) and herpes simplex virus (HSV) are common viruses that can affect critically ill patients who are not immunocompromised. The aim of this study was to determine whether the identification of CMV and/or HSV in mechanically ventilated critically ill patients suspected of having pneumonia was associated with an increased mortality.

Design: Prospective epidemiological study.

Setting: Medical intensive care unit of a tertiary medical center.

Patients: Ninety-three patients with suspected pneumonia.

Interventions: Patients with suspected pneumonia had bronchoalveolar lavage and blood samples taken to confirm the diagnosis. Antigenemia was used to detect CMV in the blood. Bronchoalveolar lavage samples were submitted to testing using quantitative real-time Polymerase Chain Reaction.

Measurements And Main Results: We identified 22 patients with a CMV infection, 26 patients with an HSV infection and 45 patients without CMV or HSV infection (control group). Mortality at day 60 was higher in patients with a CMV infection than in patients from the control group (55% vs. 20%, P<0.01). Mortality at day 60 was not significantly increased in the group with HSV infection. Duration of ICU stay and ICU mortality were significantly higher in patients with CMV infections when compared to patients from the control group, whereas ventilator free days were significantly lower in patients with CMV infections when compared to patients from the control group.

Conclusions: In critically ill patients, a CMV infection is associated with an increased mortality. Further interventional studies are needed to evaluate whether treatment could improve the prognosis.

Citing Articles

Viral reactivations and fungal infections in nonresolving acute respiratory distress syndrome.

Maessen L, Boers L, Heylen J, van Someren Greve F, Wauters J, Bos L Eur Respir Rev. 2025; 34(175).

PMID: 39971398 PMC: 11836671. DOI: 10.1183/16000617.0153-2024.


Retraction: Cytomegalovirus and Herpes Simplex Virus Effect on the Prognosis of Mechanically Ventilated Patients Suspected to Have Ventilator-Associated Pneumonia.

PLoS One. 2024; 19(10):e0312324.

PMID: 39401238 PMC: 11472917. DOI: 10.1371/journal.pone.0312324.


Towards improved management of pulmonary herpes simplex virus and cytomegalovirus in COVID-19 ARDS: a future perspective. Author's reply.

Boers L, van Someren Greve F, van Hattem J, Schinkel J, Bos L Intensive Care Med. 2024; 50(12):2197-2198.

PMID: 39382692 DOI: 10.1007/s00134-024-07671-6.


Microbial signatures predictive of short-term prognosis in severe pneumonia.

Huang S, Qiu J, Li S, Ma Y, He J, Han L Front Cell Infect Microbiol. 2024; 14:1397717.

PMID: 39157177 PMC: 11327560. DOI: 10.3389/fcimb.2024.1397717.


Pulmonary herpes simplex virus and cytomegalovirus in patients with acute respiratory distress syndrome related to COVID-19.

Boers L, van Someren Greve F, van Hattem J, de Brabander J, Zwaan T, van Willigen H Intensive Care Med. 2024; 50(8):1251-1264.

PMID: 39017695 PMC: 11306713. DOI: 10.1007/s00134-024-07529-x.


References
1.
Heininger A, Hamprecht K . How cytomegalorvirus reactivation could cause pulmonary pathology in septic hosts. Crit Care Med. 2006; 34(3):929-30. DOI: 10.1097/01.CCM.0000202442.33792.04. View

2.
Ziemann M, Sedemund-Adib B, Reiland P, Schmucker P, Hennig H . Increased mortality in long-term intensive care patients with active cytomegalovirus infection. Crit Care Med. 2008; 36(12):3145-50. DOI: 10.1097/CCM.0b013e31818f3fc4. View

3.
Chilet M, Aguilar G, Benet I, Belda J, Tormo N, Carbonell J . Virological and immunological features of active cytomegalovirus infection in nonimmunosuppressed patients in a surgical and trauma intensive care unit. J Med Virol. 2010; 82(8):1384-91. DOI: 10.1002/jmv.21825. View

4.
Limaye A, Boeckh M . CMV in critically ill patients: pathogen or bystander?. Rev Med Virol. 2010; 20(6):372-9. PMC: 2987685. DOI: 10.1002/rmv.664. View

5.
Daubin C, Vincent S, Vabret A, Du Cheyron D, Parienti J, Ramakers M . Nosocomial viral ventilator-associated pneumonia in the intensive care unit: a prospective cohort study. Intensive Care Med. 2005; 31(8):1116-22. PMC: 7079837. DOI: 10.1007/s00134-005-2706-1. View